{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:48:26Z","timestamp":1791362906739,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.medj.2023.12.011","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:37:45Z","timestamp":1706092665000},"page":"132-147.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Isoform-selective TGF-\u03b23 inhibition for systemic sclerosis"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-9393","authenticated-orcid":false,"given":"Tianhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Vander Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salil","family":"Uttarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ching","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiquan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajbharan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayurranjan","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah S.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Brightbill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lupardus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalai","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Arron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2023.12.011_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.medj.2023.12.011_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.medj.2023.12.011_bib3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2023.12.011_bib4","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2023.12.011_bib5","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2023.12.011_bib6","doi-asserted-by":"crossref","first-page":"a021873","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-beta and the TGF-beta Family: Context-Dependent Roles in Cell and Tissue Physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.medj.2023.12.011_bib7","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.medj.2023.12.011_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta--at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.medj.2023.12.011_bib9","first-page":"3","article-title":"Transforming growth factor-beta signaling in systemic sclerosis","volume":"32","author":"Ayers","year":"2018","journal-title":"J.\u00a0Biomed. Res."},{"key":"10.1016\/j.medj.2023.12.011_bib10","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.medj.2023.12.011_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/annrheumdis-2020-eular.1753","article-title":"Safety, Target Engagement, and Initial Efficacy of Avid200, a First-in-Class Potent and Isoform-Selective Inhibitor of Tgf-Beta 1 and 3, in Patients with Diffuse Cutaneous Systemic Sclerosis (Dcssc): A Phase 1 Dose Escalation Study","volume":"79","author":"Lafyatis","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2023.12.011_bib12","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1200\/JCO.2020.38.15_suppl.3587","article-title":"AVID200, first-in-class TGF-beta 1 and 3 selective and potent inhibitor: Safety and biomarker results of a phase I monotherapy dose-escalation study in patients with advanced solid tumors","volume":"38","author":"Yap","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.medj.2023.12.011_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/toxsci\/kfaa024","article-title":"A Potent Pan-TGFbeta Neutralizing Monoclonal Antibody Elicits Cardiovascular Toxicity in Mice and Cynomolgus Monkeys","volume":"175","author":"Mitra","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.medj.2023.12.011_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.22289","article-title":"Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192","volume":"56","author":"Denton","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2023.12.011_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood.V87.4.1439.bloodjournal8741439","article-title":"Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse","volume":"87","author":"Yaswen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.medj.2023.12.011_bib16","doi-asserted-by":"crossref","first-page":"eabe0407","DOI":"10.1126\/scitranslmed.abe0407","article-title":"TGFbeta2 and TGFbeta3 isoforms drive fibrotic disease pathogenesis","volume":"13","author":"Sun","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2023.12.011_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.medj.2023.12.011_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/art.40455","article-title":"Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis","volume":"70","author":"Stifano","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.medj.2023.12.011_bib19","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2023.12.011_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.medj.2023.12.011_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-1811(99)00008-0","article-title":"Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma","volume":"21","author":"Querfeld","year":"1999","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.medj.2023.12.011_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/clin.1993.1170","article-title":"Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis","volume":"69","author":"Sfikakis","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.medj.2023.12.011_bib23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#","article-title":"Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors","volume":"44","author":"Ihn","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2023.12.011_bib24","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41467-021-24607-6","article-title":"Myofibroblast transcriptome indicates SFRP2(hi) fibroblast progenitors in systemic sclerosis skin","volume":"12","author":"Tabib","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2023.12.011_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/jid.2009.318","article-title":"A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity","volume":"130","author":"Sargent","year":"2010","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.medj.2023.12.011_bib26","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2023.12.011_bib27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","article-title":"Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies","volume":"132","author":"Pendergrass","year":"2012","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.medj.2023.12.011_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0000000000000827","article-title":"Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment","volume":"33","author":"Arron","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.medj.2023.12.011_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbspin.2011.02.022","article-title":"Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap","volume":"79","author":"Gheita","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.medj.2023.12.011_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjd.12117","article-title":"Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis","volume":"168","author":"Yamaguchi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.medj.2023.12.011_bib31","doi-asserted-by":"crossref","first-page":"109695","DOI":"10.1016\/j.clim.2023.109695","article-title":"Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis","volume":"254","author":"Sheng","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.medj.2023.12.011_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13075-022-02943-2","article-title":"Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications","volume":"24","author":"El-Adili","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.medj.2023.12.011_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/rheumatology\/ker442","article-title":"Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease","volume":"51","author":"Hesselstrand","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.medj.2023.12.011_bib34","doi-asserted-by":"crossref","first-page":"a022103","DOI":"10.1101\/cshperspect.a022103","article-title":"Structural Biology and Evolution of the TGF-beta Family","volume":"8","author":"Hinck","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.medj.2023.12.011_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/mabs.3.1.13799","article-title":"Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?","volume":"3","author":"Deng","year":"2011","journal-title":"mAbs"},{"key":"10.1016\/j.medj.2023.12.011_bib36","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.xphs.2023.07.005","article-title":"Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFbeta3 Antibody for the Treatment of Fibrotic Diseases","volume":"112","author":"Yadav","year":"2023","journal-title":"J.\u00a0Pharmaceut. Sci."},{"key":"10.1016\/j.medj.2023.12.011_bib37","doi-asserted-by":"crossref","first-page":"e159566","DOI":"10.1172\/jci.insight.159566","article-title":"Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial","volume":"7","author":"Khanna","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.medj.2023.12.011_bib38","doi-asserted-by":"crossref","first-page":"eaaw0790","DOI":"10.1126\/scitranslmed.aaw0790","article-title":"Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis","volume":"11","author":"Shin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.medj.2023.12.011_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/humu.23407","article-title":"A mutation update on the LDS-associated genes TGFB2\/3 and SMAD2\/3","volume":"39","author":"Schepers","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.medj.2023.12.011_bib40","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3390\/ijms19072125","article-title":"TGF-beta Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections","volume":"19","author":"Takeda","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.medj.2023.12.011_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304874120","article-title":"A specialized integrin-binding motif enables proTGF-beta2 activation by integrin alphaVbeta6 but not alphaVbeta8","volume":"120","author":"Le","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.medj.2023.12.011_bib42","doi-asserted-by":"crossref","first-page":"108133","DOI":"10.1016\/j.isci.2023.108133","article-title":"An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease","volume":"26","author":"Jia","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.medj.2023.12.011_bib43","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.medj.2023.12.011_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.medj.2023.12.011_bib45","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.medj.2023.12.011_bib46","series-title":"Bioinformatics and Computational Biology Solutions Using R","first-page":"397","author":"Smyth","year":"2005"},{"key":"10.1016\/j.medj.2023.12.011_bib47","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.medj.2023.12.011_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41592-018-0308-4","article-title":"Fast interpolation-based t-SNE for improved visualization of single-cell RNA-seq data","volume":"16","author":"Linderman","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.medj.2023.12.011_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/nar\/27.1.209","article-title":"IMGT, the international ImMunoGeneTics database","volume":"27","author":"Lefranc","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.medj.2023.12.011_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-2836(92)91010-M","article-title":"Antibody framework residues affecting the conformation of the hypervariable loops","volume":"224","author":"Foote","year":"1992","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.medj.2023.12.011_bib51","doi-asserted-by":"crossref","first-page":"22365","DOI":"10.1038\/s41598-021-01530-w","article-title":"Dramatic activation of an antibody by a single amino acid change in framework","volume":"11","author":"Liang","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634023004099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634023004099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T16:07:51Z","timestamp":1715443671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634023004099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2666634023004099"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2023.12.011","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoform-selective TGF-\u03b23 inhibition for systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2023.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}